Ihi Launchpad, 963 Industrial Rd, Ste D, San Carlos, CA 94070, US

Iovance Biotherapeutics, based in San Carlos, CA, is a pioneering company at the forefront of transforming cancer treatment through harnessing the human immune system to target and eliminate diverse cancer cells in each patient. Their investigational TIL therapy involves collecting and growing a patient's own tumor infiltrating lymphocytes outside the body to be reinfused as a personalized treatment, with a focus on advanced solid tumor cancers. Utilizing T-cell-based immunotherapy platforms, Iovance is dedicated to developing personalized therapies that target neoantigens unique to each patient or tumor, rather than shared antigen targets. With a focus on clinical trials for various cancers, including melanoma and non-small cell lung cancer, Iovance Biotherapeutics is committed to advancing innovative approaches to combatting cancer.Generated from the website